Interdisciplinary insights into the link between gut microbiome and gastric carcinogenesis—what is currently known? Karolina Kaźmierczak-SiedleckaAgnieszka DacaKarol Połom Review Article Open access 06 November 2021 Pages: 1 - 10
Nationwide cohort study: cholesterol level is inversely related with the risk of gastric cancer among postmenopausal women Joo Hyun LimCheol Min ShinDong Ho Lee Original Article 01 September 2021 Pages: 11 - 21
Sex differences in tumor characteristics, treatment, and outcomes of gastric and esophageal cancer surgery: nationwide cohort data from the Dutch Upper GI Cancer Audit Marianne C. KalffAnna D. Wagnerthe Dutch Upper GI Cancer Audit group Original Article Open access 07 August 2021 Pages: 22 - 32
Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study Young Min KimJie-Hyun KimHyojin Park Original Article 05 August 2021 Pages: 33 - 41
Correction to: Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study Young Min KimJie-Hyun KimHyojin Park Correction 31 August 2021 Pages: 42 - 43
Hypoxia associated lncRNA HYPAL promotes proliferation of gastric cancer as ceRNA by sponging miR-431-5p to upregulate CDK14 Hai-yan PiaoYang LiuJun Zhang Original Article 11 July 2021 Pages: 44 - 63
CircTMC5 promotes gastric cancer progression and metastasis by targeting miR-361-3p/RABL6 Peng XuXiaoLan XuAMan Xu Original Article 22 July 2021 Pages: 64 - 82
Genomic landscape of a mouse model of diffuse-type gastric adenocarcinoma Menghua ZhangItsuki SugitaShumpei Ishikawa Original Article Open access 13 August 2021 Pages: 83 - 95
Synergistic effects of Rapamycin and Fluorouracil to treat a gastric tumor in a PTEN conditional deletion mouse model Cong-hui ZhuShuang-qing PengChengfang Pang Original Article 09 August 2021 Pages: 96 - 106
Insulin and the insulin receptor collaborate to promote human gastric cancer Marina SaisanaS. Michael GriffinFelicity E. B. May Original Article Open access 23 September 2021 Pages: 107 - 123
Integrin β1 orchestrates the abnormal cell-matrix attachment and invasive behaviour of E-cadherin dysfunctional cells Joana FigueiredoRui M. FerreiraRaquel Seruca Original Article Open access 05 September 2021 Pages: 124 - 137
Molecular classification of gastric cancer predicts survival in patients undergoing radical gastrectomy based on project HOPE Kenichiro FurukawaKeiichi HatakeyamaKen Yamaguchi Original Article 02 September 2021 Pages: 138 - 148
Glucose metabolic profiles evaluated by PET associated with molecular characteristic landscape of gastric cancer Seong-Woo BaeFelix BerlthHan-Kwang Yang Original Article 07 August 2021 Pages: 149 - 160
Brain metastases in gastroesophageal cancers—an underestimated complication Marius BrunnerDominik SollAlexander König Original Article Open access 23 July 2021 Pages: 161 - 169
Radiological criteria for selecting candidates for neoadjuvant chemotherapy for gastric cancer: an exploratory analysis from the PRODIGY study Hyung-Don KimJong Seok LeeYoon-Koo Kang Original Article 02 September 2021 Pages: 170 - 179
Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction: KSCC1601 Masaaki IwatsukiHiroyuki OritaMasaki Mori Original Article 11 August 2021 Pages: 180 - 187
Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07 Yoshihiro KakejiKazuhiro YoshidaMasashi Fujii Original Article 05 August 2021 Pages: 188 - 196
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial Charles S. FuchsMustafa ÖzgüroğluKohei Shitara Original Article Open access 01 September 2021 Pages: 197 - 206
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study Yoon-Koo KangSatoshi MoritaNarikazu Boku Original Article Open access 04 September 2021 Pages: 207 - 217
New response evaluation criteria using early morphological change in imatinib treatment for patients with gastrointestinal stromal tumor Tomo IshidaTsuyoshi TakahashiYuichiro Doki Original Article 20 August 2021 Pages: 218 - 225
Insertion–deletion rate is a qualitative aspect of the tumor mutation burden associated with the clinical outcomes of gastric cancer patients treated with nivolumab Hyung-Don KimMin-Hee RyuYoon-Koo Kang Original Article 01 September 2021 Pages: 226 - 234
Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08) Yoshikazu TakahashiYu SunakawaMasashi Fujii Original Article 24 August 2021 Pages: 235 - 244
Real-world safety and effectiveness of nivolumab in Japanese patients with unresectable advanced or recurrent gastric/gastroesophageal junction cancer that has progressed after chemotherapy: a postmarketing surveillance study Kensei YamaguchiNarikazu BokuTakeshi Sano Original Article Open access 28 September 2021 Pages: 245 - 253
Correction to: Real-world safety and effectiveness of nivolumab in Japanese patients with unresectable advanced or recurrent gastric/gastroesophageal junction cancer that has progressed after chemotherapy: a postmarketing surveillance study Kensei YamaguchiNarikazu BokuTakeshi Sano Correction 09 November 2021 Pages: 254 - 254
Development of a predictive model for extragastric recurrence after curative resection for early gastric cancer Jae Seok BaeWon ChangJoon Koo Han Original Article 21 July 2021 Pages: 255 - 264
Remission of type 2 diabetes after gastrectomy for gastric cancer: diabetes prediction score Yeongkeun KwonJin-Won KwonSungsoo Park Original Article 22 July 2021 Pages: 265 - 274
Trends in clinical outcomes and long-term survival after robotic gastrectomy for gastric cancer: a single high-volume center experience of consecutive 2000 patients Seohee ChoiJeong Ho SongWoo Jin Hyung Original Article 17 August 2021 Pages: 275 - 286
Risk factors and oncological impact of positive resection margins in gastrectomy for cancer: are they salvaged by an additional resection? Yusuke MuneokaManabu OhashiSouya Nunobe Original Article 22 August 2021 Pages: 287 - 296
Correction to: DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial–mesenchymal transition in gastric cancer Yu LiangChun-Dong ZhangDong-Qiu Dai Correction 09 November 2021 Pages: 297 - 298
